This paper is only available as a PDF. To read, Please Download here.
A human hepatoma cell line, Hep G2, which synthesizes and secretes several components of the fibrinolytic system, was examined for the capacity to produce plasminogen activator (PA). PA activity was found to accumulate in medium conditioned by the cells but was not detected in cell extracts. Analysis of Hep G2 conditioned medium by SDS-polyacrylamide gel electrophoresis revealed multiple PAs of Mr 100,000, 60,000, and 52,000 daltons. In addition, a heterogeneous band of activity was present between the 100,000 and 60,000 dalton PAs. All detectable PA activity in conditioned medium fractionated at a single position after isoelectric focusing. The isoelectric point of this material (pl 8.6) was identical to that of purified urokinase. Anti-urokinase IgG, but not anti-tissue activator IgG, neutralized the activity of these PAs. Treatment of conditioned medium with 25 mM diisopropylfluorophosphate for 5 hr at 37 °C inactivated the 52,000 and 60,000 dalton PAs but had no effect on the 100,000 dalton PA or the heterogeneous zone of activity. The possibility that the absence of detectable PA activity in the cell extracts resulted from the presence of fibrinolytic inhibitors was considered. Addition of cell extract to purified urokinase resulted in a concentration-dependent reduction of urokinase-mediated fibrinolytic activity, consistent with the presence of such inhibitors. Acidification of the cell extracts to inactivate the inhibitor(s) revealed the presence of a latent, cell-associated PA activity. Thus, in addition to the other major components of the fibrinolytic system, Hep G2 cells produce multiple forms of a urokinase-like PA. Detection of these PAs may be obscured by the presence of cellular inhibitors.
Abbreviations:plasminogen activator ((PA)), tissue PA ((t-PA)), minimal essential medium ((MEM)), phosphate-buffered saline ((PBS)), conditioned medium ((CM)), diisopropylfluorophosphate ((DFP)), sodium dodecyl sulfate-polyacrylamide gel electrophoresis ((SDS-PAGE)), molecular weight or relative molecular mass ((Mr)), isoelectric point ((pI))
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Translational Research
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- On the regulation and control of fibrinolysis.Thromb Haemost. 1980; 43: 77
- The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin.J Biol Chem. 1967; 242: 2333
- Immunological characterization of plasminogen activator activities in human body tissues and fluids.J Lab Clin Med. 1981; 97: 477
- Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.J Biol Chem. 1981; 256: 7035
- Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.J Biol Chem. 1982; 257: 2912
- Production by human tissues in culture of immunologically distinct, multiple molecular weight forms of plasminogen activators.Ann NY Acad Sci. 1981; 370: 592
- Isolation and characterization of urokinase from human plasma.J Biol Chem. 1982; 257: 3276
- Relationship between tissue plasminogen activator and the activators in blood and vascular wall.Thromb Res. 1980; 18: 815
- Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.Science. 1980; 209: 497
- Synthesis and secretion of the fibrinolytic components, including α2-antiplasmin, by a human hepatoma cell line.J Lab Clin Med. 1983; 101: 372
- Synthesis and secretion of α2 plasmin inhibitor by established human liver cell lines.in: ed. 2. Proc Natl Acad Sci USA. 79. 1982: 5684
- Cultured bovine endothelial cells produce both urokinase and tissue type plasminogen activators.J Cell Biol. 1982; 94: 631
- Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.in: ed. 2. Proc Natl Acad Sci USA. 74. 1977: 3903
- Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature. 1970; 227: 680
- A study of protease-inhibitor complexes in biological fluids.J Exp Med. 1978; 148: 223
- A rapid and sensitive method for the quantisation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem. 1976; 12: 248
- Plasminogen purification from human plasma by affinity chromatography.Science. 1970; 170: 1095
- The preparation of human fibrinogen free of plasminogen.Biochim Biophys Acta. 1962; 57: 204
- Physiological inhibitors of fibrinolysis.in: Gaffney PJ Balkuv-Ulutin S Fibrinolysis: Current Fundamental and Clinical Concepts. Academic Press, Inc, New York1978: 17
- Immunological characterization of multiple molecular weight forms of human plasminogen activators.J Biol Chem. 1979; 254: 575
- Molecular species of plasminogen activators secreted by normal and neoplastic human cells.Cancer Res. 1980; 40: 933
- Comparative studies of the fibrinolytic activity of cultured vascular cells.Thromb Res. 1979; 15: 869
Accepted: May 31, 1983
Received: February 14, 1983
☆Supported by NIH Research Grant 16411.
☆☆Publication No. 2864 from the Immunology Department of the Research Institute of Scripps Clinic.
© 1983 Published by Elsevier Inc.